Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?
Authors:
- Charles R. ScogginsCSCharles R. Scoggins
- 1 December 2010
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 200 (6) , 759-764
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Mitotic Rate in MelanomaAmerican Journal of Clinical Pathology, 2007
- Predictors of Regional Nodal Disease in Patients With Thin MelanomasAnnals of Surgical Oncology, 2006
- Prognosticators of melanoma, the melanoma report, and the sentinel lymph nodeLaboratory Investigation, 2006
- Thin Primary Cutaneous Malignant Melanoma: A Prognostic Tree for 10-Year Metastasis Is More Accurate Than American Joint Committee on Cancer StagingJournal of Clinical Oncology, 2004
- Lessons learned from the Sunbelt Melanoma TrialJournal of Surgical Oncology, 2004
- Thin MelanomasAnnals of Surgery, 2003
- The Risk of Regional Lymph Node Metastases in Patients with Melanoma Less Than 1.0 Mm Thick: Recommendations for Sentinel Lymph Node BiopsyJournal of the American College of Surgeons, 2003
- Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanomaCancer, 2003
- Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC)European Journal of Cancer, 2002
- Sentinel Lymph Node Biopsy for Melanoma: How Many Radioactive Nodes Should be Removed?Annals of Surgical Oncology, 2001